Menu

Search

Helen Hodgson

Helen Hodgson

Associate Professor, Curtin Law School and Curtin Business School, Curtin University
Helen Hodgson (B.Bus; PGrad Dip Business (Bus Law), MTax, PhD) is an Associate Professor in Taxation in the Curtin Law School at Curtin Business School. Her areas of research include tax policy, the tax-transfer system, superannuation and the taxation of small business entities, and is particularly interested in the gender impacts of the system. Her PhD was a comparison of the Family Tax Transfer systems in Australia and the UK. She attended the Australia's Future Tax System Forum in 2010. Helen has been at UNSW since 2004, and at ECU and Curtin University in Western Australia between 1989 and 2004. From 1997 to 2001 Helen was a Member of the Legislative Council in WA, representing the Australian Democrats in the North Metropolitan Region. She is a Fellow of CPA Australia, a Chartered Tax Advisor and a member of SPAA.

Should I put more money into my super? What are the benefits and can I take it out before retirement if I need it?

Apr 05, 2023 13:21 pm UTC| Investing

Superannuation is never far from the headlines lately, with the government recently calling for views from the public on what the objective of super should be. The basic idea behind super is you set aside a portion of...

New modelling finds investing in childcare and aged care almost pays for itself

Oct 20, 2020 00:05 am UTC| Business Investing

In the absence of an official analysis of the impact of the budget by gender the National Foundation for Australian Women has this morning published its own gender analysis of the budget, across multiple dimensions. It...

Robo-debt is only one way government stigmatises claimants. There's only so much a class action can do

Sep 22, 2019 14:08 pm UTC| Insights & Views Technology

The robo-debt recovery programme has been criticised as badly designed and unfair ever since it began in mid 2016. A year later the Senate Committee on Community Affairs recommended it be put on hold until its design...

Please, not another super scheme, Mr Keating. It's what the pension is for

Oct 28, 2018 13:14 pm UTC| Insights & Views Politics

Talk about a solution seeking a problem. Former prime minister Paul Keating this week called for a national insurance scheme to support Australians aged 80 and over. He says it will be needed to pay medical and other...

1 

Economy

Asian Stocks Mixed as China, Japan Factory Data Disappoint; India, Korea Decline on Geopolitical Risks

Asian stock markets were mostly flat on Wednesday as investors weighed weak factory activity data from China and Japan, alongside Australian inflation figures and heightened regional tensions. Chinas official manufacturing...

Oil Prices Dip Amid Tariff Concerns, Rising Inventories, and OPEC+ Output Worries

Oil prices slipped in early Asian trading Wednesday, pressured by renewed concerns over global economic growth and fuel demand due to U.S. tariff policies and rising crude inventories. Brent crude futures fell 17 cents, or...

U.S. Stock Futures Dip as Investors Monitor Trade Developments, Earnings, and Key Data

U.S. stock futures slipped Tuesday evening as investors digested signs of easing trade tensions, soft economic data, and awaited major corporate earnings. SP 500 futures fell 0.2% to 5,571.75, while Nasdaq 100 futures...

India Eyes Swift U.S. Trade Deal with Rare Forward MFN Clause

India is accelerating trade talks with the U.S., offering significant concessions to secure a fast-track deal ahead of President Donald Trumps proposed 26% reciprocal tariff deadline in July. According to Indian government...

Sweden’s Q1 2025 GDP Stalls, Missing Growth Forecasts

Swedens economy stagnated in the first quarter of 2025, with gross domestic product (GDP) showing no growth compared to the previous three months, according to preliminary data from the Statistics Office released Tuesday....

Politics

Trump Touts Economic Record, Promises Tax Cuts at Michigan Rally Amid Recession Fears

President Donald Trump rallied supporters in Warren, Michigan, marking his first 100 days in office with bold claims about the U.S. economy, promises of sweeping tax cuts, and sharp criticism of Democrats. Speaking near...

Tensions Escalate as China, U.S., and Philippines Conduct Rival Patrols in South China Sea

Chinas navy conducted a patrol in the South China Sea on Tuesday, accusing the Philippines of provocations as Filipino and U.S. forces carried out joint aerial patrols over the disputed waters. The move comes amid rising...

U.S. Defense Secretary Scraps Women, Peace and Security Program Citing Military Focus

U.S. Defense Secretary Pete Hegseth announced Tuesday the cancellation of the Women, Peace, and Security (WPS) program, originally enacted by President Donald Trump in 2017 to promote womens participation in global peace...

U.S. Urges India and Pakistan to Avoid Escalation After Kashmir Attack

U.S. Secretary of State Marco Rubio is set to hold talks with his Indian and Pakistani counterparts in an effort to prevent further escalation following a deadly militant attack in India-administered Kashmir. The State...

Trump Jokes About Becoming Pope After Death of Francis

U.S. President Donald Trump joked on Tuesday that hed like to succeed Pope Francis, who passed away last week at the age of 88. When asked who he would prefer as the next leader of the Catholic Church, Trump quipped, Id...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Xiaomi Unveils MiMo AI Model, Shares Surge 5% on Breakthrough Launch

Xiaomi Corp (HK:1810) launched its first open-source large language model, MiMo, on Wednesday, marking its official entry into the competitive artificial intelligence space. The debut sent Xiaomis Hong Kong-listed shares...

Alibaba Launches Qwen 3 AI Model Amid Intensifying China Tech Competition

Chinese tech giant Alibaba Group (NYSE:BABA) unveiled Qwen 3 on Tuesday, a next-generation AI model featuring hybrid reasoning capabilities aimed at boosting performance and adaptability. The move underscores Alibabas...

Amazon Enters Satellite Internet Race with First Kuiper Deployment

Amazon (NASDAQ:AMZN) has officially entered the satellite broadband market with the successful launch of 27 operational satellites for Project Kuiper, its high-speed internet initiative aimed at rivaling SpaceXs Starlink....

Chinese AI App DeepSeek Resumes Downloads in South Korea After Privacy Update

Chinese artificial intelligence app DeepSeek has resumed availability in South Koreas app stores after a two-month suspension due to data protection concerns. Downloads were halted in February when South Koreas Personal...

Nvidia Shares Dip as Huawei Tests Rival AI Chip

Nvidia Corporation (NASDAQ: NVDA) slipped in after-hours trading on Sunday, following reports that Chinas Huawei is testing a powerful artificial intelligence chip aimed at challenging Nvidias dominance. NVDA shares fell...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.